πŸ” Pharmidex In Silico Drug Discovery – Step 3: Determination of Active/Binding Sites! πŸŽ―πŸ’»
February 25, 2025

At Pharmidex, we continue to push the boundaries of computational drug discovery! Following target structure and ligand determination, our advanced Determination of Active/Binding Sites step ensures precise identification of key molecular interactions, optimizing drug design for success.


✨ Why is this step crucial?

βœ… Accurate identification of binding pockets for targeted drug interactions

βœ… AI-powered pocket detection and molecular dynamics simulations

βœ… Enhanced precision in hit identification and lead optimization

βœ… Seamless integration with our next in silico pipeline steps


By leveraging cutting-edge computational tools, we de-risk drug development and accelerate therapeutic innovation. Stay tuned for the next stage in our in silico pipeline!


πŸ“½οΈ Watch our latest video (2/5) to explore how we map active sites with precision!


πŸ“© Let’s collaborate to revolutionize drug discovery!


#DrugDiscovery #Pharmidex #AIinBiotech #MolecularModeling #PharmaceuticalInnovation

We’re Hiring! Senior/Principal Scientist–In Vivo Pharmacologist
July 30, 2025
We’re Hiring! Senior/Principal Scientist–In Vivo Pharmacologist
July 28, 2025
We’re delighted to welcome Gabrielle Georgiou and Dr. Mohammed Ahmad from the University of Hertfordshire as they begin their first experience in a scientific CRO environment here at Pharmidex ! This partnership is an exciting step in fostering early-career scientific talent by offering hands-on exposure to real-world drug discovery and preclinical research. A big thank you to the University of Hertfordshire for partnering with us to support the next generation of innovators. We’re proud to play a role in shaping future leaders in science through meaningful, practical learning opportunities. πŸ‘©‍πŸ”¬ πŸ‘¨‍πŸ”¬ Welcome to the team, Gabrielle and Mohammed!
BATA Taste Aversion
July 24, 2025
At Pharmidex , we offer Brief Access Taste Aversion (BATA) testing, which is a behavioural assay that quantifies how test subjects respond to different compounds or formulations by measuring lick response and aversion. This helps identify: βœ… Bitter-tasting APIs βœ… Unpalatable excipients βœ… The success of taste-masking strategies βœ… Formulation-dependent compliance risks Get in touch if you’re developing oral formulations, paediatric drugs, or repurposing bitter APIs, this could be the data your IND package needs.
More Posts